Compare Elastic NV (ESTC) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elastic NV vs Eli Lilly And Co — how do they compare? Elastic NV trades at $75.22 (market cap $7.93B), while Eli Lilly And Co trades at $1,215 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 138.7× Elastic NV's market cap, and Eli Lilly And Co pays a 0.56% dividend while Elastic NV pays none. Which is the better fit depends on your goals.
| ESTC | LLY | |
|---|---|---|
Market Cap | $7.93B | $1.10T |
Sector | Technology | Health |
52-Week High | $94.47 | $1.24K |
52-Week Low | $43.30 | $639.43 |
Enterprise Value | $7.15B | $1.14T |
Dividend Yield | — | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Elastic N.V. (ESTC) trades at $75.11, up 7.38% in the past 24 hours, with a bullish technical signal and strong analyst consensus. Recent earnings beats, including Q1 2026 EPS of $0.61 versus $0.561 expected, highlight operational strength. The company announced AI collaborations with OpenAI and AWS security distinctions, driving positive sentiment.
Outlook remains positive due to growth prospects in AI and security, but risks include high valuation multiples and ongoing legal investigations. The stock offers upside to the consensus price target of $74.21, though investors should weigh profitability improvements against competitive pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
